Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?

Abstract

The discovery that mesenchymal stem cells (MSCs) are recruited into tumors has led to a great deal of interest over the past decade in the function of MSCs in tumors. To address this, investigators have used a variety of tumor models in which MSCs are added exogenously to determine their impact on tumor development. Interestingly, many studies have reported contradicting results, with some investigators finding that MSCs promote tumor growth and others reporting that MSCs inhibit tumor growth. Many mechanisms have been reported to account for these observations, such as chemokine signaling, modulation of apoptosis, vascular support, and immune modulation. In this review, we analyzed the differences in the methodology of the studies reported and found that the timing of MSC introduction into tumors may be a critical element. Understanding the conditions in which MSCs enhance tumor growth and metastasis is crucial, both to safely develop MSCs as a therapeutic tool and to advance our understanding of the role of tumor stroma in carcinogenesis.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 100

1. 1.

   Hata N, Shinojima N, Gumin J, et al. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas. Neurosurgery. 2010;66:144-156.

   Not in our library10.1227/01.neu.0000363149.58885.2e

2. 2.

   Kidd S, Spaeth E, Dembinski JL, et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells. 2009;27:2614-2623.

   Not in our library10.1002/stem.187

3. 3.
   Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression · 2009

   Corrected
4. 4.

   Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449:557-563.

   Not in our library10.1038/nature06188

5. 5.

   Zhu W, Xu W, Jiang R, et al. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol. 2006;80:267-274.

   Not in our library10.1016/j.yexmp.2005.07.004

6. 6.

   Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood. 2003;102:3837-3844.

   Not in our library10.1182/blood-2003-04-1193

7. 7.

   Djouad F, Bony C, Apparailly F, et al. Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells. Transplantation. 2006;82:1060-1066.

   Not in our library10.1097/01.tp.0000236098.13804.0b

8. 8.

   Muehlberg F, Song YH, Krohn A, et al. Tissue resident stem cells promote breast cancer growth and metastasis. Carcinogenesis. 2009;30:589-597.

   Not in our library10.1093/carcin/bgp036

9. 9.

   Yu JM, Jun ES, Bae YC, Jung JS. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev. 2008;17:463-473.

   Not in our library10.1089/scd.2007.0181

10. 10.

    Galie M, Konstantinidou G, Peroni D, et al. Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice. Oncogene. 2008;27:2542-2551.

    Not in our library10.1038/sj.onc.1210920

11. 11.

    Lin G, Yang R, Banie L, et al. Effects of transplantation of adipose tissue-derived stem cells on prostate tumor. Prostate. 2010;70:1066-1073.

    Not in our library10.1002/pros.21140

12. 12.
    Tumor cell behaviour modulation by mesenchymal stromal cells · 2010

    No notice
13. 13.

    Prantl L, Muehlberg F, Navone NM, et al. Adipose tissue-derived stem cells promote prostate tumor growth. Prostate. 2010;70:1709-1715.

    Not in our library10.1002/pros.21206

14. 14.

    Shinagawa K, Kitadai Y, Tanaka M, et al. Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int J Cancer. 2010;127:2323-2333.

    Not in our library10.1002/ijc.25440

15. 15.

    Torsvik A, Rosland GV, Svendsen A, et al. Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: Putting the research field on track - letter. Cancer Res. 2010;70:6393-6396.

    Not in our library10.1158/0008-5472.can-10-1305

16. 16.

    Khakoo AY, Pati S, Anderson SA, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med. 2006;203:1235-1247.

    Not in our library10.1084/jem.20051921

17. 17.

    Qiao L, Xu Z, Zhao T, et al. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res. 2008;18:500-507.

    Not in our library10.1038/cr.2008.40

18. 18.

    Qiao L, Xu ZL, Zhao TJ, et al. Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett. 2008;269:67-77.

    Not in our library10.1016/j.canlet.2008.04.032

19. 19.

    Zhu Y, Sun Z, Han Q, et al. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia. 2009;23:925-933.

    Not in our library10.1038/leu.2008.384

20. 20.

    Otsu K, Das S, Houser SD, et al. Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood. 2009;113:4197-4205.

    Not in our library10.1182/blood-2008-09-176198

21. 21.
    Adult Stromal Cells Derived from Human Adipose Tissue Provoke Pancreatic Cancer Cell Death both In Vitro and In Vivo · 2009

    No notice
22. 22.

    Maestroni GJ, Hertens E, Galli P. Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice. Cell Mol Life Sci. 1999;55:663-667.

    Not in our library10.1007/s000180050322

23. 23.

    Lu YR, Yuan Y, Wang XJ, et al. The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol Ther. 2008;7:245-251.

    Not in our library10.4161/cbt.7.2.5296

24. 24.

    Dasari VR, Velpula KK, Kaur K, et al. Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP). PLoS One. 2010;5:e11813.

    Not in our library10.1371/journal.pone.0011813

25. 25.
    Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway. · 2010

    Not checked
26. 26.
    Human Bone Marrow Mesenchymal Stem Cells Display Anti-Cancer Activity in SCID Mice Bearing Disseminated Non-Hodgkin's Lymphoma Xenografts · 2010

    No notice
27. 27.

    Yong RL, Shinojima N, Fueyo J, et al. Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas. Cancer Res. 2009;69:8932-8940.

    Not in our library10.1158/0008-5472.can-08-3873

28. 28.

    Kidd S, Caldwell L, Dietrich M, et al. Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment. Cytotherapy. 2010;12:615-625.

    Not in our library10.3109/14653241003631815

29. 29.

    Mader EK, Maeyama Y, Lin Y, et al. Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model. Clin Cancer Res. 2009;15:7246-7255.

    Not in our library10.1158/1078-0432.ccr-09-1292

30. 30.

    Studeny M, Marini FC, Dembinski JL, et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst. 2004;96:1593-1603.

    Not in our library10.1093/jnci/djh299

31. 31.

    Nakamizo A, Marini F, Amano T, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005;65:3307-3318.

    Not in our library10.1158/0008-5472.can-04-1874

32. 32.

    Studeny M, Marini FC, Champlin RE, et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 2002;62:3603-3608.

    Not in our library

33. 33.

    Kim SM, Lim JY, Park SI, et al. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res. 2008;68:9614-9623.

    Not in our library10.1158/0008-5472.can-08-0451

34. 34.

    Josiah DT, Zhu D, Dreher F, et al. Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma. Mol Ther. 2010;18:377-385.

    Not in our library10.1038/mt.2009.265

35. 35.

    Dwyer RM, Khan S, Barry FP, et al. Advances in mesenchymal stem cell-mediated gene therapy for cancer. Stem Cell Res Ther. 2010;1:2010-2025.

    Not in our library10.1186/scrt25

36. 36.

    Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.

    Not in our library10.1126/science.284.5411.143

37. 37.

    Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society For Cellular Therapy position statement. Cytotherapy. 2006;8:315-317.

    Not in our library10.1080/14653240600855905

38. 38.

    Pereira RF, Halford KW, O'Hara MD, et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA. 1995;92:4857-4861.

    Not in our library10.1073/pnas.92.11.4857

39. 39.

    Shih YR, Kuo TK, Yang AH, et al. Isolation and characterization of stem cells from the human parathyroid gland. Cell Prolif. 2009;42:461-470.

    Not in our library10.1111/j.1365-2184.2009.00614.x

40. 40.

    Dubois SG, Floyd EZ, Zvonic S, et al. Isolation of human adipose-derived stem cells from biopsies and liposuction specimens. Methods Mol Biol. 2008;449:69-79.

    Not in our library10.1007/978-1-60327-169-1_5

Cited by papers we hold 20

• Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions · 2024
  No notice
• Mesenchymal stem cells accelerated growth and metastasis of neuroblastoma and preferentially homed towards both primary and metastatic loci in orthotopic neuroblastoma model · 2021
  Not checked
• The Role of Mesenchymal Stromal Cells-Derived Small Extracellular Vesicles in Diabetes and Its Chronic Complications · 2021
  Not checked
• Mesenchymal stem cells promote caspase-3 expression of SH-SY5Y neuroblastoma cells via reducing telomerase activity and telomere length · 2021
  Not checked
• Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities · 2021
  No notice
• Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines · 2021
  No notice
• Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer · 2019
  No notice
• Mesenchymal stromal cells in cancer: a review of their immunomodulatory functions and dual effects on tumor progression · 2019
  No notice
• Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival · 2018
  Not checked
• Potential Effect of Exosomes Derived from Cancer Stem Cells and MSCs on Progression of DEN-Induced HCC in Rats · 2018
  No notice
• CRISPR/Cas9-Mediated Knockin Application in Cell Therapy: A Non-viral Procedure for Bystander Treatment of Glioma in Mice · 2017
  Not checked
• Mesenchymal stem cells: key players in cancer progression · 2017
  No notice
• Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based Therapy · 2016
  No notice
• Exosomes from human colorectal cancer induce a tumor-like behavior in colonic mesenchymal stromal cells · 2016
  No notice
• Interaction of MSC with tumor cells · 2016
  No notice
• Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression · 2015
  No notice
• Exosomes Derived from Mesenchymal Stem Cells Suppress Angiogenesis by Down-Regulating VEGF Expression in Breast Cancer Cells · 2013
  No notice
• Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors · 2013
  No notice
• Microvesicles Derived from Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cells Attenuate Bladder Tumor Cell Growth In Vitro and In Vivo · 2013
  No notice
• Mesenchymal Stem Cell 1 (MSC1)-Based Therapy Attenuates Tumor Growth Whereas MSC2-Treatment Promotes Tumor Growth and Metastasis · 2012
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.